Results of a phase II study investigating Nivolumab for treatment of relapsed follicular lymphoma. (Abstract only)
Home / Resource Library / Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma